Aurinia Early Urinary Protein Reduction Predicts Response
Clinical trial NCT02949973 · COMPLETED
Trial details
- NCT number
- NCT02949973
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.